SynoJoynt® 1% Sodium Hyaluronate

This animation highlights the clinical benefits of SynoJoynt® 1% sodium hyaluronate, a high-molecular-weight, non–cross-linked sodium hyaluronate indicated for osteoarthritis pain of the knee in patients who have failed to adequately respond to conservative, nonpharmacologic therapy and simple analgesics. SynoJoynt sodium hyaluronate is derived from bacterial fermentation and is proven safe and effective in a 3-dose regimen.¹

^Reference

^{1. US Food and Drug Administration. Summary of safety and effectiveness (SSED) for SynoJoynt. Accessed January 5, 2022. https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170016B.pdf}